Journal List > Korean J Gastroenterol > v.62(6) > 1007173

Choi, Kim, Han, Yoon, Chae, Youn, Kang, Sung, Choi, and Park: Clinical, Pathological, and Immunohistochemical Features of Adenomyoma in the Ampulla of Vater

Abstract

Background/Aims

Ampullary adenomyoma is a benign lesion whose malignant potential has yet to be confirmed. Despite its benign nature, adenomyoma is frequently misdiagnosed as a carcinoma or adenoma and is overtreated by extensive surgery. This study was performed to analyze the clinical, pathological, and immunohistochemical features of adenomyomas in the ampulla of Vater.

Methods

Nine cases of adenomyoma in the ampulla of Vater, diagnosed in Chungbuk National University Hospital between 2008 and 2011, were enrolled in this study. We reviewed the clinical data on the symptoms, laboratory data, and radiologic findings of the abdominal computed tomography and endoscopic retrograde cholangiopancreatography. For pathological analysis, all the slides were reviewed by one pathologist, and immunohistochemical stainings with antibodies against cytokeratin 7 (CK7), cytokeratin 20 (CK20), α-smooth muscle actin (α-SMA), and Ki-67 antigen were performed.

Results

All the cases were CK7 positive and CK20 negative. A strong cytoplasmic expression of α-SMA was confirmed in all cases. The Ki-67 index was less than 1% in eight cases and 5% in one case. Four cases underwent endoscopic papillectomy, and one case received surgical ampullectomy during colorectal cancer surgery. Five cases that underwent endoscopic or surgical treatment remained symptom-free for three years. Four cases that were closely observed with repeated endoscopic examinations exhibited no interval changes in the papillary lesions.

Conclusions

Endoscopic biopsy and immunohistochemistry can aid in the diagnosis of ampullary adenomyomas. Endoscopic papillectomy or surgical ampullectomy is adequate for the treatment of symptomatic ampullary adenomyomas.

References

1. Handra-Luca A, Terris B, Couvelard A, Bonte H, Flejou JF. Adenomyoma and adenomyomatous hyperplasia of the Vaterian system: clinical, pathological, and new immunohistochemical features of 13 cases. Mod Pathol. 2003; 16:530–536.
crossref
2. Albores-Saavedra JH, Sobin LH, Gibson JB. Histological typing of tumours of the gallbladder and extrahepatic bile ducts. Berlin: Springer-Verlag;1991.
3. Hammarström LE, Holmin T, Stenram U. Adenomyoma of the ampulla of Vater: an uncommon cause of bile duct obstruction. Surg Laparosc Endosc. 1997; 7:388–393.
4. Narita T, Yokoyama M. Adenomyomatous hyperplasia of the papilla of Vater: A sequela of chronic papillitis? Ann Diagn Pathol. 1999; 3:174–177.
crossref
5. Clarke BE. Myoepithelial hamartoma of the gastrointestinal tract. Arch Pathol. 1940; 30:143–152.
6. Fernandez-Cruz L, Pera C. A histological study of the sphincter of Oddi. In: Delmont J, ed. The sphincter of Oddi. Proceedings of the 3rd Gastroenterology Symposium. Nice: Gastroenterology Symposium. 1976. 13–20.
7. Kim JW, Jang JY, Han SS, Choi MK, Kim SH, Park YH. Adenomyoma of the Vaterian ampulla. Korean J Hepatobiliary Pancreat Surg. 2004; 8:258–261.
8. Jang KT, Heo JS, Choi SH, et al. Adenomyoma of ampulla of Vater or the common bile duct: a report of three cases. Korean J Pathol. 2005; 39:59–62.
9. Kwon TH, Park do H, Shim KY, et al. Ampullary adenomyoma presenting as acute recurrent pancreatitis. World J Gastroenterol. 2007; 13:2892–2894.
crossref
10. Lee BU, Bang JS, Yang SH, et al. A case of ampullary adenomyoma associated with dilatations of pancreatic and biliary ducts. Korean J Gastrointest Endosc. 2010; 40:391–395.
11. Menzel J, Poremba C, Dietl KH, Böcker W, Domschke W. Tumors of the papilla of Vater–inadequate diagnostic impact of endoscopic forceps biopsies taken prior to and following sphincterotomy. Ann Oncol. 1999; 10:1227–1231.
12. Bedirli A, Patiroglu TE, Sozuer EM, Sakrak O. Periampullary adenomyoma: report of two cases. Surg Today. 2002; 32:1016–1018.
13. Kayahara M, Ohta T, Kitagawa H, Miwa K, Urabe T, Murata T. Adenomyomatosis of the papilla of Vater: a case illustrating diagnostic difficulties. Dig Surg. 2001; 18:139–142.
crossref
14. Läuffer JM, Baer HU, Maurer CA, et al. Adenomyoma of the distal common bile duct mimicking cholangiocarcinoma. Dig Dis Sci. 1998; 43:1200–1204.
15. Higashi M, Goto M, Saitou M, et al. Immunohistochemical study of mucin expression in periampullary adenomyoma. J Hepatobiliary Pancreat Sci. 2010; 17:275–283.
crossref
16. Duval JV, Savas L, Banner BF. Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder. Arch Pathol Lab Med. 2000; 124:1196–1200.
crossref
17. Sheehan M, O'Briain DS. False-positive immunoreactivity with muscle-specific actins in non-Hodgkin's lymphomas. Arch Pathol Lab Med. 1995; 119:225–228.
18. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000; 182:311–322.
crossref

Fig. 1.
Radiologic findings of adenomyomas in the ampulla of Vater. Abdominal CT (A, axial view; B, coronal view) showed a 1.4-cm mass protruding into the duodenal lumen with a dilated common bile duct (arrows). (C) Endoscopic retrograde cholangiopancreatography showed a dilated biliary tract (arrow).
kjg-62-352f1.tif
Fig. 2.
Endoscopic view of ampullary adenomyomas. Enlarged major papilla and villous and granular mucosa around the papillary orifice could be identified in all cases; each case matched from A to I.
kjg-62-352f2.tif
Fig. 3.
Pathological and immunohistochemical features of adenomyomas in the ampulla of Vater. (A) Hyperplastic glandular lobules covered by a single layer of epithelium were surrounded by hyperplastic mesenchymal tissues composed of muscle fibers, fibroblasts, myofibroblasts, and capillaries (H&E, ×200). (B) Immunohistochemical staining with the Ki67 antibody level detected at less than 1% (×40). (C, D) α-SMA expression (arrows) in the myofibroblastic component (×40 and ×400, respectively). (E, F) Strong CK7 expression (arrows) in the epithelial lining of the glandular structures (×40 and ×400, respectively). (G, H) No CK20 expression (arrows) in the epithelial lining of the glandular structures (×40 and ×400, respectively).
kjg-62-352f3.tif
Fig. 4.
Endoscopic papillectomy for an ampullary adenomyoma. (A) Endoscopic papillectomy was performed after pancreatic stent insertion. (B) Endoscopic view of the stent placed in the biliary duct after papillectomy. (C) Endoscopic papillectomy was performed without prior pancreatic stent insertion. (D) Endoscopic view of the major papilla after papillectomy.
kjg-62-352f4.tif
Table 1.
Clinical Features of Nine Cases of Ampullary Adenomyoma
Case Age (yr)/sex Clinical symptom CT finding Endoscopic finding Endoscopic biopsy AST/ALT (IU/L) ALP (IU/L) T-bil (mg/dL) Treatment
1 70/M Abdominal pain Focal enhancing lesion at AOV and CBD dilation (14 mm) 15 mm sized ampullary mass with granularity Adenomyoma 78/30 268 0.57 Endoscopic papillectomy
2 71/M Abdominal pain Nonspecific finding 12 mm sized ampullary mass Adenomyoma 55/92 432 1.83 Endoscopic papillectomy
3 72/M Incidental 15×12 mm sized well defined nodule at AOV and CBD dilatation (13 mm) 12 mm sized ampullary mass with villous mucosa Dysplasia →adenomyoma 25/11 180 0.36 Endoscopic papillectomy
4 53/M Abdominal pain Nonspecific finding 10 mm sized lobulated lesion Chronic inflammation →adenomyoma 25/33 300 1.46 Endoscopic papillectomy
5 75/M Incidental (colon cancer) Focal enhancing lesion at AOV with diffuse IHD and CBD dilatation (11 mm) Bulging and lobulated papilla Adenomyoma 17/15 230 0.55 Surgical ampullectomy
6 75/F Incidental Mass (11 mm) at AOV, IHD and CBD dilatation (10 mm) Bulging and lobulated papilla Adenomyoma 23/16 251 0.36 Close observation
7 64/F Incidental CBD dilatation (10 mm) Bulging papilla Adenomyoma 44/33 178 0.60 Close observation
8 57/F Incidental Nonspecific finding Enlarged and lobulated papilla Atypical epithelial proliferation → adenomyoma 36/29 174 1.02 Close observation
9 65/F Incidental Not performed Bulging and lobulated papilla Adenomyoma 29/28 273 0.56 Close observation

M, male; F, female; AOV, ampulla of Vater; CBD, common bile duct; IHD, intrahepatic duct; T-bil, total bilirubin.

Table 2.
Clinical Features of Four Cases of Ampullary Adenomyoma Reported in the Literature
Year published Age (yr)/ sex Clinical symptom CT finding Endoscopic finding Endoscopic biopsy AST/ALT (IU/L) ALP (IU/L) T-bil (mg/dL) Treatment
20047 69/M Hyperbilirubinemia Mass at CBD with diffuse BD and PD dilatation Normal AOV Chronic inflammation 33/13 62 1.8 Pancreaticoduod enectomy
20058 56/M Mild jaundice Mass at AOV with BD dilatation Sessile mass Focal nuclear atypia Normal 350 2.1 Surgical ampullectomy
20079 74/F Abdominal pain (pancreatitis) Diffuse dilated CBD without focal mass Even and firm nodular mass with a granular and villous mucosa (after EST) Muscle proliferation without atypia 31/11 85 1.3 Piecemeal resection with an electro-cautery snare
201010 69/M Abdominal pain/ anorexia Diffuse BD and PD dilatation Bulging and lobulated papilla Focal adenoma 57/20 85 0.9 Endoscopic papillectomy

M, male; F, female; CBD, common bile duct; BD, bile duct; PD, pancreatic duct; AOV, ampulla of Vater; EST, endoscopic sphincterotomy; T-bil, total bilirubin.

TOOLS
Similar articles